Skip to main content

ERRATUM article

Front. Oncol., 26 September 2023
Sec. Cancer Genetics

Erratum: Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer

by Tian Y, Xie T and Sun X (2022) Front. Oncol. 12:1059591. doi: 10.3389/fonc.2022.1059591

Due to a production error, there was an error regarding the authorship for Yin Tian” and “Tao Xie”. Both authors should have been listed as co-first authors. The publisher apologizes for this mistake.

The original version of this article has been updated.

Keywords: thyroid cancer, immune gene, prognosis, miRNA, targeted combination

Citation: Frontiers Production Office (2023) Erratum: Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer. Front. Oncol. 13:1281583. doi: 10.3389/fonc.2023.1281583

Received: 22 August 2023; Accepted: 22 August 2023;
Published: 26 September 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.